toggle mobile menu Menu
toggle search menu

Site Navigation

Supplemental

Menu

Hemolytic disease of the newborn

Hemolytic disease of the newborn

Hemolytic disease of the newborn (also called erythroblastosis fetalis) is a serious condition that may occur when the blood types of you and your baby do not match. Substances (antibodies) in your blood cross the placenta and may destroy the red blood cells of the fetus.

After birth, a baby with hemolytic disease may be treated with a blood transfusion.

Current as of: October 24, 2024

Author: Ignite Healthwise, LLC Staff

Clinical Review Board
All Healthwise education is reviewed by a team that includes physicians, nurses, advanced practitioners, registered dieticians, and other healthcare professionals.

This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Healthwise is a URAC accredited health web site content provider. Privacy Policy. How this information was developed to help you make better health decisions.

© 1995- Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.